Blood-pool enhancement with SH U 508 A. Results of phase II clinical trials.
Schlief
R
R
Clinical Development Diagnostics, Schering AG, Berlin, Germany.
Schürmann
R
R
Niendorf
H P
HP
D003287:Contrast Media / Q000008:administration & dosage / Q000009:adverse effects; D004341:Drug Evaluation; D004361:Drug Tolerance; D004452:Echocardiography; D005690:Galactose / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans
D003287:Contrast Media; D005690:Galactose